Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSCofrogliptin is a long-acting inhibitor of dipeptidyl peptidase 4 (DPP-4; IC50 = 10.8 nM).1 It is selective for DPP-4 over DPP-8 and DPP-9 (IC50s = >100 µM for both) and a panel of 127 receptors, ion channels, transporters, and enzymes at 10 µM. Cofrogliptin (10 mg/kg) decreases blood glucose levels, increases serum insulin levels, and inhibits serum DPP-4 activity in an oral glucose tolerance test using db/db mice.
WARNING This product is not for human or veterinary use.
1. Preclinical pharmacological profiles of cofrogliptin, a novel and bi-